Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON CIPLA BIOCON /
CIPLA
 
P/E (TTM) x 34.7 36.1 96.2% View Chart
P/BV x 4.3 4.4 97.5% View Chart
Dividend Yield % 0.2 0.4 38.6%  

Financials

 BIOCON    CIPLA
EQUITY SHARE DATA
    BIOCON
Mar-22
CIPLA
Mar-22
BIOCON /
CIPLA
5-Yr Chart
Click to enlarge
High Rs4241,083 39.2%   
Low Rs315806 39.1%   
Sales per share (Unadj.) Rs68.2269.7 25.3%  
Earnings per share (Unadj.) Rs8.231.7 25.7%  
Cash flow per share (Unadj.) Rs14.944.8 33.4%  
Dividends per share (Unadj.) Rs0.505.00 10.0%  
Avg Dividend yield %0.10.5 25.6%  
Book value per share (Unadj.) Rs68.5257.8 26.6%  
Shares outstanding (eoy) m1,200.60806.81 148.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.43.5 154.8%   
Avg P/E ratio x45.329.8 152.2%  
P/CF ratio (eoy) x24.721.1 117.3%  
Price / Book Value ratio x5.43.7 147.1%  
Dividend payout %6.115.8 38.9%   
Avg Mkt Cap Rs m443,622762,177 58.2%   
No. of employees `000NANA-   
Total wages/salary Rs m18,80135,299 53.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m81,840217,633 37.6%  
Other income Rs m6,8913,217 214.2%   
Total revenues Rs m88,731220,851 40.2%   
Gross profit Rs m13,82743,298 31.9%  
Depreciation Rs m8,14210,520 77.4%   
Interest Rs m6761,064 63.6%   
Profit before tax Rs m11,90034,933 34.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1159,338 22.6%   
Profit after tax Rs m9,78525,595 38.2%  
Gross profit margin %16.919.9 84.9%  
Effective tax rate %17.826.7 66.5%   
Net profit margin %12.011.8 101.7%  
BALANCE SHEET DATA
Current assets Rs m83,823147,108 57.0%   
Current liabilities Rs m38,28049,129 77.9%   
Net working cap to sales %55.645.0 123.6%  
Current ratio x2.23.0 73.1%  
Inventory Days Days10163 160.1%  
Debtors Days Days926 1,598.3%  
Net fixed assets Rs m117,184119,415 98.1%   
Share capital Rs m6,0031,614 372.0%   
"Free" reserves Rs m76,281206,364 37.0%   
Net worth Rs m82,284207,977 39.6%   
Long term debt Rs m39,9854,162 960.6%   
Total assets Rs m201,007266,523 75.4%  
Interest coverage x18.633.8 55.0%   
Debt to equity ratio x0.50 2,428.0%  
Sales to assets ratio x0.40.8 49.9%   
Return on assets %5.210.0 52.0%  
Return on equity %11.912.3 96.6%  
Return on capital %10.317.0 60.6%  
Exports to sales %026.2 0.0%   
Imports to sales %7.88.2 95.0%   
Exports (fob) Rs mNA57,094 0.0%   
Imports (cif) Rs m6,36017,803 35.7%   
Fx inflow Rs m8,88560,180 14.8%   
Fx outflow Rs m6,36017,803 35.7%   
Net fx Rs m2,52542,376 6.0%   
CASH FLOW
From Operations Rs m11,76633,259 35.4%  
From Investments Rs m-16,991-18,719 90.8%  
From Financial Activity Rs m2,421-15,998 -15.1%  
Net Cashflow Rs m-2,433-1,323 183.9%  

Share Holding

Indian Promoters % 39.7 13.5 294.5%  
Foreign collaborators % 20.9 20.1 103.9%  
Indian inst/Mut Fund % 24.0 49.0 49.1%  
FIIs % 16.3 27.6 59.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 66.4 59.3%  
Shareholders   341,016 418,910 81.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    PIRAMAL ENTERPRISES    


More on Biocon vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs Cipla Share Price Performance

Period Biocon Cipla S&P BSE HEALTHCARE
1-Day 1.51% 1.07% 0.67%
1-Month 1.23% 11.44% 3.92%
1-Year -18.77% 19.30% -11.12%
3-Year CAGR 8.63% 39.80% 24.50%
5-Year CAGR -2.70% 14.47% 11.40%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of Cipla the stake stands at 33.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.1%.

Cipla paid Rs 5.0, and its dividend payout ratio stood at 15.8%.

You may visit here to review the dividend history of Biocon, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Rallies 1,200 Points, Nifty Above 17,200; IndusInd Bank, Bajaj Finance & Adani Ports Surge 4%(10:30 am)

Asian share markets opened higher today after Wall Street shares rebounded, with the rise coming despite a North Korean missile test shortly before the opening bell.